Clinical Trial Update: Rosuvastatin in the Treatment of Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rosuvastatin for rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED